Friday, July 10, 2026

Drug profile · INN

technetium tc-99m tilmanocept

technetium tc-99m tilmanocept (LYMPHOSEEK KIT) is a diagnostic. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — technetium tc-99m tilmanocept
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

technetium tc-99m tilmanocept (LYMPHOSEEK KIT) is a diagnostic. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN technetium tc-99m tilmanocept
Brand LYMPHOSEEK KIT
Mechanism Diagnostic
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Diagnostic

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is technetium tc-99m tilmanocept?

technetium tc-99m tilmanocept (LYMPHOSEEK KIT) is a diagnostic. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for technetium tc-99m tilmanocept?

LYMPHOSEEK KIT is a marketed brand name for technetium tc-99m tilmanocept. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of technetium tc-99m tilmanocept?

technetium tc-99m tilmanocept has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.